ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Allarity Therapeutics Inc

Allarity Therapeutics Inc (ALLR)

0.163
-0.005
(-2.98%)
Closed July 23 4:00PM
0.1601
-0.0039
(-2.38%)
After Hours: 7:59PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.1601
Bid
0.1616
Ask
0.2977
Volume
5,600,789
0.1421 Day's Range 0.1695
0.1421 52 Week Range 69.00
Market Cap
Previous Close
0.168
Open
0.1676
Last Trade Time
Financial Volume
$ 871,008
VWAP
0.155515
Average Volume (3m)
6,271,927
Shares Outstanding
17,606,739
Dividend Yield
-
PE Ratio
-0.14
Earnings Per Share (EPS)
-1.16
Revenue
-
Net Profit
-20.42M

About Allarity Therapeutics Inc

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. Allarity Therapeutics Inc is a clinical-stage, precision medicine company.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Allarity Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALLR. The last closing price for Allarity Therapeutics was $0.17. Over the last year, Allarity Therapeutics shares have traded in a share price range of $ 0.1421 to $ 69.00.

Allarity Therapeutics currently has 17,606,739 shares outstanding. The market capitalization of Allarity Therapeutics is $2.96 million. Allarity Therapeutics has a price to earnings ratio (PE ratio) of -0.14.

ALLR Latest News

Allarity Therapeutics Outlines Companyโ€™s 2024 Progress and Objectives

ย  Current Cash Balance of $20 million Expected to Provide Runway Into 2026Allarity to Pause Use of ATMCap Table Successfully Cleaned UpAllarityโ€™s Stenoparib Shows Extended Duration of Phase 2...

Allarity Granted Hearing Before Nasdaq Panel to Present Plan of Regaining Compliance

Boston (June 27, 2024) โ€” Allarity Therapeutics, Inc. (โ€œAllarityโ€ or the โ€œCompanyโ€) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer...

Allarity Therapeuticsโ€™ Dual PARP/Tankyrase Inhibitor, Stenoparib, Continues to Show Extended Clinical Benefit in Advanced Ovarian Cancer

Multiple patients have now exceeded 30 weeks on treatment Boston (June 25, 2024)โ€”Allarity Therapeutics, Inc. (โ€œAllarityโ€ or the โ€œCompanyโ€) (NASDAQ: ALLR), a Phase 2 clinical-stage...

Allarity Therapeutics Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

Boston (May 20, 2024)โ€”Allarity Therapeutics, Inc. (โ€œAllarityโ€ or the โ€œCompanyโ€) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0362-18.44116148750.19630.24840.142153142300.19242789CS
4-0.1845-53.54033662220.34460.3530.142159887610.20764556CS
12-1.3199-89.18243243241.483.460.142162719270.6898606CS
26-8.4399-98.1383720938.69.60.142132675161.0554731CS
52-59.4399-99.731375838959.6690.142121410305.3265157CS
1562220700.83135-100.000007209-2220700.67125123520-1484398.551871742192-15562.1111304CS
2602220700.83135-100.000007209-2220700.67125123520-1484398.551871742192-15562.1111304CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MIRAMIRA Pharmaceuticals Inc
$ 5.01
(627.35%)
158.15M
CMAXCareMax Inc
$ 5.19
(228.48%)
102.64M
NUKKNukkleus Inc
$ 0.499
(55.94%)
26.2M
SNOASonoma Pharmaceuticals Inc
$ 0.423
(37.34%)
4.88M
ONDSOndas Holdings Inc
$ 1.1297
(34.06%)
2.19M
CGBSCrown LNG Holdings Ltd
$ 0.9902
(-29.77%)
3.29M
LGCBLinkage Global Inc
$ 3.7833
(-27.45%)
166.7k
SPECSpectaire Holdings Inc
$ 0.395
(-24.76%)
1.78M
GSUNGolden Sun Health Technology Group Ltd
$ 5.07
(-24.55%)
155.37k
SLNASelina Hospitality PLC
$ 0.0364
(-23.04%)
75.77M
NVDANVIDIA Corporation
$ 123.54
(4.76%)
239M
SQQQProShares UltraPro Short QQQ
$ 8.09
(-4.37%)
183.65M
MIRAMIRA Pharmaceuticals Inc
$ 5.01
(627.35%)
158.15M
SERVServe Robotics Inc
$ 8.73
(15.63%)
151.56M
NCPLNetcapital Inc
$ 0.1118
(7.50%)
124.37M

ALLR Discussion

View Posts
TheOTCstocksGuy TheOTCstocksGuy 13 hours ago
Absolute trash!! Been saying it for months but no one listens as usual!!
๐Ÿ‘๏ธ0
gdog gdog 16 hours ago
pretty much
๐Ÿ‘๏ธ0
 just Scottie just Scottie 16 hours ago
In the toilet now
๐Ÿ‘๏ธ0
gdog gdog 18 hours ago
ALLR recieves a well notice trade accordingly
๐Ÿ‘๏ธ0
 just Scottie just Scottie 3 days ago
I havenโ€™t been a shareholder long enough I guess. I didnโ€™t get an email.
I guess to vote on the RS, stock options lol and new officers
๐Ÿ‘๏ธ0
gdog gdog 3 days ago
gosh i don't know I usually just delete without looking much what does it look like?
๐Ÿ‘๏ธ0
 just Scottie just Scottie 3 days ago
Did u get an email to vote for the split?
๐Ÿ‘๏ธ0
gdog gdog 3 days ago
agree
๐Ÿ‘๏ธ0
 just Scottie just Scottie 3 days ago
Getting an extension and postpone the split and get some good news is the only way we stave off the wolves
๐Ÿ‘๏ธ0
 just Scottie just Scottie 3 days ago
Someone just said short shares are over $3 million
๐Ÿ‘๏ธ0
gdog gdog 3 days ago
yup lets see how far they take it down am also done buying.
๐Ÿ‘๏ธ0
 just Scottie just Scottie 3 days ago
Iโ€™m afraid to ave down again
Every time I have it plunges more
๐Ÿ‘๏ธ0
 just Scottie just Scottie 3 days ago
Yes big time
๐Ÿ‘๏ธ0
gdog gdog 3 days ago
lol i was typing as you were posting yes we need g/news
๐Ÿ‘๏ธ0
gdog gdog 3 days ago
yes I'm down a good bit also we need good news and hurry
๐Ÿ‘๏ธ0
 just Scottie just Scottie 3 days ago
Company needs to majorly combat this with some good news
๐Ÿ‘๏ธ0
gdog gdog 3 days ago
that was ending 6-30
๐Ÿ‘๏ธ0
gdog gdog 3 days ago
https://www.marketbeat.com/stocks/NASDAQ/ALLR/short-interest/
700,000 sold short in the last 2 wks
๐Ÿ‘๏ธ0
 just Scottie just Scottie 3 days ago
They are doing a good job. Lost my ass
Doesnโ€™t help if the company may be selling too
๐Ÿ‘๏ธ0
gdog gdog 3 days ago
I added a few today gulp all markets down today. the shorts are trying to destroy it
๐Ÿ‘๏ธ0
 just Scottie just Scottie 3 days ago
Selling is relentless brother. Where the hell does it all come from
๐Ÿ‘๏ธ0
 just Scottie just Scottie 6 days ago
That will be great
๐Ÿ‘๏ธ0
gdog gdog 6 days ago
understood still think buyout
๐Ÿ‘๏ธ0
 just Scottie just Scottie 6 days ago
Well unfortunately they need to maintain a dollar to stay on the daq
๐Ÿ‘๏ธ0
gdog gdog 6 days ago
17.5 m outstanding don't let people worry you about an RS
๐Ÿ‘๏ธ0
 just Scottie just Scottie 6 days ago
Gonna be tough sledding here. So much downward pressure due to the RS threat
Shorts and pump and dumpers have the upper hand
๐Ÿ‘๏ธ0
gdog gdog 6 days ago
few hundred isn't wwhat I'm looking for I wants k's
look https://investorshub.advfn.com/Bottom-Swing-Plays-29717
๐Ÿ‘๏ธ0
 just Scottie just Scottie 6 days ago
Everyone dumped from 18 cents
Hoping news of new trial comes today
๐Ÿ‘๏ธ0
gdog gdog 6 days ago
BUY out coming ??????????
๐Ÿ‘๏ธ0
Law of Averages Law of Averages 6 days ago
Agreed. ALLR moving up hella quick.
๐Ÿ‘๏ธ0
 just Scottie just Scottie 6 days ago
Shorty could shit themselves here soon.
👍️ 1
Zardiw Zardiw 6 days ago
Stop sugar coating it.......say it like it is...........

Z
๐Ÿ‘๏ธ0
 just Scottie just Scottie 1 week ago
$ALLR THESE PARTS OF THE LAST PR STAND OUT TO ME. TELLS ME THEY ARE ACTIVELY LOOKING FOR PARTNERS OR BUYOUT. THEY HAVE GOTTEN VERY GOOD RESULTS, SO GOOD THEY STOPPED THE LAST TRIAL EARLY. YOU DONโ€™T DO THAT UNLESS THE PATIENTS HAVE BENIFITTED. FDA COULD COME I AND FAST FRACK THIS. ITS JUST MEANT TO EXTEND LIFE ON ADVANCED OVARIAN CANCER PATIENTS. SOFAR THEY HAVE PROVED IT SHRINKS TUMOR SIZE.
โ€œNot only does the safety profile stand out when compared to chemotherapies, which is often the alternative for this patient group, but the safety metrics are indeed also favorable when compared to first-generation PARP inhibitors. As we see it, stenoparib may represent the next-generation alternative for advanced ovarian cancer patients. Therefore, we are aggressively working with Dr. Moore and other leading experts to design a trial that will help advance and quicken stenoparibโ€™s clinical progress toward registration with the FDA.โ€

โ€œAfter conducting a detailed review of the stenoparib monotherapy trial data, including the data announced today, the Company has concluded that these data may be of significant interest among key oncologists, potential commercial partners, and other relevant stakeholders and therefore warrant presentation within a high-level scientific conference. Further release of these clinical data is intended to be staged to comply with the common rules of scientific conferences, which do not allow data to be published before the event.โ€

The PARP inhibitor market is expected to reach $22 billion in revenue by 2028, and has historically seen significant partnerships and acquisitions.

For example, one significant acquisition included a multi-asset deal potentially totaling $1.5 billion, which featured an advanced PARP inhibitor.

Allarity has exclusive global rights for the development and commercialization of stenoparib, which was originally developed by Eisai Co. Ltd. and was formerly known under the names E7449 and 2X-121.


๐Ÿ‘๏ธ0
TheOTCstocksGuy TheOTCstocksGuy 3 weeks ago
More trash stinking up the markets!! Get this POS delisted and out of here!!
๐Ÿ‘๏ธ0
 just Scottie just Scottie 3 weeks ago
U too my man
๐Ÿ‘๏ธ0
gdog gdog 3 weeks ago
Have a great 4th.
๐Ÿ‘๏ธ0
 just Scottie just Scottie 3 weeks ago
Iโ€™m thinking the same especially if itโ€™s got the FDA involved
👍️ 1
gdog gdog 3 weeks ago
still holding all I still believe this will run. the next trial will really make it fly if its favorable.
๐Ÿ‘๏ธ0
 just Scottie just Scottie 3 weeks ago
Whatcha thinking on what is happening now bro?
๐Ÿ‘๏ธ0
 just Scottie just Scottie 4 weeks ago
Agreed, i loaded today at 20 cents
๐Ÿ‘๏ธ0
gdog gdog 4 weeks ago
I think the shorts are giving share holders a gift at these prices, if this passes Phase three ---- look out shorty
๐Ÿ‘๏ธ0
 just Scottie just Scottie 4 weeks ago
Now would be a good time to throw everything and the kitchen sink to stabilize this and kill the short attack
๐Ÿ‘๏ธ0
eyeownu eyeownu 4 weeks ago
IF the os/float is not increasing than it's nss. everyone is saying dilution. my only issue is why do they dilute at .30- 20 cents when they could do it much higher. maybe the said dilution volume is from the buyer. all imo
๐Ÿ‘๏ธ0
 just Scottie just Scottie 4 weeks ago
Definitely shenanigans
If the RS shorts will attack and bring it down again
They need an alternative. Partnerships joint venture or buyout
๐Ÿ‘๏ธ0
eyeownu eyeownu 4 weeks ago
buys and sells almost equal. dark pool vol was 60% of total traded today. what the fruk shorts got this one in death grip. but everything is purposeful and deliberate. i am thinking they sell some assets as well to keep them from being banished to the otc.
๐Ÿ‘๏ธ0
 just Scottie just Scottie 4 weeks ago
Yes what Iโ€™m hoping for is a buyout from a big firm.
They are only in phase 2, generally the norm is phase 4 before itโ€™s approved
👍️ 1
gdog gdog 4 weeks ago
ALLR has a product thats doing well ( i know its a huge gamble at this stage) shorts will have to cover sooner or later.
๐Ÿ‘๏ธ0
 just Scottie just Scottie 4 weeks ago
This shorting shit should be illegal
๐Ÿ‘๏ธ0
 just Scottie just Scottie 4 weeks ago
Thereโ€™s no bottom to tell, they will keep attacking. They have the threat of delisting and RS unfortunately
๐Ÿ‘๏ธ0
gdog gdog 4 weeks ago
I'm watching trying to figure how low it will go, I'm not giving up on it thats for sure.
๐Ÿ‘๏ธ0